Table 1. Benign Nodular Lesios M imicking HCC 1. Nodular hyperplasias 1) Focal nodular hyperplasia 2) Nodular regenerative hyperplasias 3) Large regenerative nodules 2. Benign epithelial tumors 1) Hepatocellular adenoma 2) H ile duct adenoma (peribiliary gland hamartoma) → von M yenburg complex (biliary hamartoma) 3. Vasoformative tumorous lesions 1) Cavernous hemangioma → Sclerosed hemangioma ...

background and aims. reactive hyperplastic lesions of the oral connective tissue are associated with injuries of soft tissue and have high prevalence rates and different involvement patterns in different parts of the world. the aim of this study was to analyze demographic data of a university department. materials and methods. patient records of the department of oral pathology during a four-ye...

BACKGROUND This study aimed to characterize the histopathological pattern of lymph node pathology among Saudi patients and to highlight the age and gender variations of these lesions as base line data. MATERIALS AND METHODS We retrospectively analyzed the data from lymph node biopsy specimens received at the Department of Pathology, King Fahad Hospital, Madinah, Saudi Arabia from January 2006...

Using monoclonal antibodies (MoAbs) and dual-parameter flow cytometric techniques, bone marrow mononuclear cells (MMC) from patients with resurgent hyperplasia were analyzed for their coexpression of HLe-1 (T200) and antigens normally associated with particular stages of B cell differentiation. The marrow from those with resurgent hyperplasia contained increased numbers of B cell precursors in ...

INTRODUCTION Intravascular papillary endothelial hyperplasia is a reactive proliferative lesion of endothelial cells in blood vessels. It typically presents as a painless, reddish purple lesion in the sites affected. The orbit remains an uncommon site of affectation of this relatively common disease. It is noteworthy that this is the first reported case, to the best of our knowledge, of orbital...

Histological staining of reactive stroma has been shown to be a predictor of biochemical recurrence in prostate cancer, however, molecular markers of the stromal response to prostate cancer have not yet been fully delineated. The objective of this study was to determine whether or not the stromal biomarkers detected with a thioredoxin-targeted nanodevice could be used to distinguish the stroma ...